Cancer Researchers Receive Grant to Study Indolent Neuroblastoma Grant awarded to CHOP and collaborating institutions will fund research into identifying and treating slowly progressive neuroblastoma, which currently lacks treatment options
News provided by
Share this article
Share this article
PHILADELPHIA, April 20, 2021 /PRNewswire/ A trans-Atlantic collaborative group of researchers led by Children s Hospital of Philadelphia (CHOP) has received approximately $680,000 from a group of research charities led by Solving Kids Cancer UK to study slowly progressive, or indolent, neuroblastoma, which does not respond to chemotherapy and lacks other treatment options. The grant will fund research that could ultimately lead to better diagnosis of this form of the disease, as well as targeted treatment options.